Publications
Vous trouverez ci-dessous la liste des publications dans lesquelles un chercheur de l’équipe METHODS figure en tant que premier ou dernier auteur.
SPIRIT 2025 statement: updated guideline for protocols of randomized trials
28/04/2025
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
28/04/2025
SPIRIT 2025 statement: updated guideline for protocols of randomised trials
28/04/2025
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials
28/04/2025
Cumulative Burden of Digital Health Technologies for Patients With Multimorbidity: A Systematic Review
25/04/2025
Improving the completeness and transparency of protocols and reports of randomized trials: SPIRIT 2025 and CONSORT 2025
19/04/2025
CONSORT 2025 statement: updated guideline for reporting randomised trials
17/04/2025
CONSORT 2025 statement: updated guideline for reporting randomized trials
14/04/2025
CONSORT 2025 statement: updated guideline for reporting randomised trials
14/04/2025
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
14/04/2025
Maternal and neonatal outcomes of pregnancies after metabolic bariatric surgery: a retrospective population-based study
11/04/2025
Lights and Shadows of Bariatric Surgery: Insights from a Nationwide Administrative Database of People Living with Type 1 Diabetes and Obesity
11/04/2025
Digital Medicine Tools and the Work of Being a Patient: A Qualitative Investigation of Digital Treatment Burden in Patients With Diabetes
10/04/2025
Correction: Response to functional restoration in non-specific chronic low back pain with Modic type 1 changes
31/03/2025
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials
25/03/2025
Biological research on mental pain, social pain and other pains not primarily felt in the body: methodological systematic review
21/03/2025
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial
03/03/2025